Abstract
The expression, inducibility, and regulation of four different cytochrome (cyt.) P-450 isoenzymes (PB1, PB2, MC1, and MC2) NADPH-cytochrome P-450 reductase, the glutathione transferases (GSTs) B and C and microsomal epoxide hydrolase (mEHb) have been studied during nitrosamine-induced hepatocarcinogenesis using immunohistochemical techniques. The investigations revealed basic differences in the expression of the individual drug metabolizing enzymes in the course of neoplastic development. While the two GSTs and mEHb were increased in all preneoplastic and benign neoplastic lesions, the levels of the distinct cyt. P-450 isoenzymes were characteristically different from each other. Following initial changes in the expression of these enzymes in early preneoplastic lesions (i. e., increase of cyt. P-450 PB1 versus slight decrease of the other cyt. P-450 isoenzymes), a continuous reduction of all cyt. P-450 isoenzymes was observed during the further course of hepatocarcinogenesis. In progressed neoplastic nodules, all cyt. P-450-isoenzymes and NADPH cyt. P-450 reductase were decreased to varying extents.
Treatment of animals with inducers of the monooxygenase system, such as phenobarbital, 3-methylcholanthrene and polychlorinated biphenyls, led to a rather heterogenous pattern of enzyme alterations in preneoplastic and neoplastic lesions. Following administration of phenobarbital, some islets responded to the same degree as the surrounding tissue, others were less or not at all inducible and a few of the lesions showed a prominent increase in cyt. P-450 PB2 and NADPH-cyt. P-450 reductase levels. The interesting finding that these two enzymes always showed concurrent changes may be indicative of a common regulation. Similar to phenobarbital, an induction of cyt. P-450 isoenzymes within carcinogen-induced lesions was also observed following administration of 3-methyl-cholanthrene or polychlorinated biphenyls.
The results demonstrate that drug-metabolizing enzymes are abnormally regulated in carcinogen-induced lesions. The multiplicity of enzyme deviations within individual lesions and especially the enzyme inducibility strongly suggest that the focal enzyme alterations result from genotoxic effects of the carcinogen on regulatory systems of a higher order rather than from mutational events in individual structural genes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aström A, De Pierre JW, Eriksson L (1983) Characterization of drug-metabolizing systems in hyperplastic nodules from the livers of rats receiving 2-acetylaminofluorene in their diet. Carcinogenesis 4: 577–581
Bannasch P, Mayer D, Hacker HJ (1980) Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 605:217–245
Bannasch P, Hacker JH, Klimek F, Mayer D (1984) Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. In: Weber G (ed) Advances in enzyme regulation, Vol 22. Pergamon Press, Oxford, pp 97–121
Bentley P, Oesch F (1975) Purification of rat liver epoxide hydrolase to apparent homogeneity, FEBS Lett 59: 291–295
Bock KW, Lilienblum W, Pfeil H, Eriksson LC (1982) Increased uridine diphosphate-glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas. Cancer Res 42: 3747–3752
Buchmann A, Kuhlmann W, Schwarz M, Kunz W, Wolf CR, Moll E, Friedberg T, Oesch F (1985) Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver. Carcinogenesis 6: 513–521
Buchmann A, Kuhlmann WD, Kunz W, Wolf R, Oesch F (1983) Differential control of cytochrome P-450 isoenzymes in the course of chemical hepatocarcinogenesis in the rat. Cancer Res Clin Oncol 105: A16
Cameron R, Sweeney GD, Jones K, Lee G, Farber E (1976) A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo(a)pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. Cancer Res 36: 3888–3893
Conney AH (1967) Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 19: 317–365
Emmelot P, Scherer E (1980) The first relevant stage in rat liver carcinogenesis: a quantitative approach Biochim Biophys Acta 605: 247–304
Enomoto K, Ying TS, Griffin MJ, Farber E (1981) Immunohistochemical study of epoxide hydrolase during experimental liver carcinogenesis. Cancer Res 41: 3281–3287
Farber E (1980) The sequential analysis of liver cancer induction. Biochim Biophys Acta 605: 149–166
Friedberg T, Milbert U, Bentley P, Guenthner TM, Oesch F (1983) Purification and characterisation of a new cytosolic glutathione S-transferase (X) from rat liver. Biochem J 215: 617–625
Gillette JR, Davis DC, Sasame HA (1972) Cytochrome P-450 and its role in drug metabolism. Ann Rev Pharmacol 12: 57–84
Hotchkis RD (1948) A microchemical reaction resulting in the staining of polysaccharide structures in fixed tissue preparation. Arch Biochem 16: 131–141
Kuhlmann WD, Krischan R, Kunz W, Guenthner TM, Oesch F (1981) Focal elevation of liver microsomal epoxide hydrolase in early preneoplastic stages and its behaviour in the further course of hepatocarcinogenesis. Biochem Biophys Res Commun 98: 417–423
Lojda J, Gossrau R, Schiebler TH (1976) Enzymhistochemische Methoden. Springer-Verlag, Heidelberg pp 182–184
Magee PN, Pegg AE, Swann PF (1975) Molecular mechanisms of chemical carcinogens. In: Altmann HW et al. (eds) Handbuch der allgemeinen Pathologie, Springer-Verlag, Berlin, pp 329–419
Oesch F, Timms CW, Walker CH, Guenthner TM, Sparrow A, Watanabe T, Wolf CR (1984) Existence of multiple forms of microsomal epoxide hydrolase with radically different substrate specificities. Carcinogenesis 5: 7–9
Okita K, Noda K, Fukumoto Y, Takemoto T (1976) Cytochrome P-450 in hyperplastic liver nodules during hepatocarcinogenesis with N-2-fluorenylacetamide in rats. Gann 67: 899–902
Schulte-Hermann R, Roome N, Timmermann-Trosiener I, Schup-pler J (1984) Immunocytochemical demonstration of a phenobarbital-inducible cytochrome P-450 in putative preneoplastic foci of rat liver. Carcinogenesis 5: 143–153
Schulte-Hermann R (1985) Tumor promotion in the liver. Arch Toxicol 57: 147–158
Sugimura T, Ikeda K, Hirota K, Hozumi M, Morris HP (1966) Chemical, enzymatic and cytochrome assays of microsomal fraction of hepatomas of different growth rates. Cancer Res 26: 1711–1716
Tatematsu M, Mera Y, Ito N, Satoh K, Sato K (1985) Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of γ-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis 6: 1621–1626
Wachstein M, Meisel E (1957) Histochemistry of hepatic phosphatases at a physiological pH. Am J Clin Pathol 27: 13–23
Weber G, Kizaki H, Shiotani T, Tzeng D, Williams JC (1978) The molecular correlation concept of neoplasia: Recent advances and new challenges. In: Advances in experimental medicine and biology, Vol. 92, Criss WE, Moris HP (eds), Plenum Press, New York/London pp 89–116
Wolf CR, Oesch F (1983) Isolation of a high spin form of cytochrome P-450 induced in rat liver by 3-methylcholanthrene. Biochem Biophys Res Commun 11: 504–511
Wolf CR, Moll E, Friedberg T, Oesch F, Buchmann A, Kuhlmann WD, Kunz HW (1984) Characterisation, localisation and regulation of a novel phenobarbital-inducible form of cytochrome P-450 compared with three further cyt. P-450 isoenzymes, NADPH P-450 reductase, glutathione transferases and microsomal epoxide hydrolase. Carcinogensis 5: 993–1001
Wolf CR (1986) Cytochrome P-450: A polymorphic multigene family involved in carcinogen metabolism. Trends in Genetics: 209–214
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. Herbert Remmer on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Kunz, H.W., Buchmann, A., Schwarz, M. et al. Expression and inducibility of drug-metabolizing enzymes in preneoplastic and neoplastic lesions of rat liver during nitrosamine-induced hepatocarcinogenesis. Arch Toxicol 60, 198–203 (1987). https://doi.org/10.1007/BF00296980
Issue Date:
DOI: https://doi.org/10.1007/BF00296980